In the media

Pioneering stem cell treatment for Crohn’s Disease

By Rikki Loftus

Yahoo! News

Aug 23, 2022

PA Consulting’s Paul Stroemer, cell and gene therapy expert, comments on the use of pioneering stem cell treatment for Cohn’s disease in an article in Yahoo! by Rikki Loftus.

Explaining how the therapy could help, Paul explained that: “In the case of Crohn’s disease, it’s likely that stem cells called Mesenchymal Stem cells (MSCs) will be used, because of their efficacy in treating immune and inflammatory diseases.”

 “These stem cells can turn into many different types of cells, including bone, fat, connective tissue, and blood vessels.

Adding: “After administration, MSCs release growth factors and anti-oxidants, helping to repair cells and tissue in their immediate vicinity. They also release soluble factors that flow through the body affecting other tissues and organs.”

Stem cells also respond to their environments and can interact with white blood cells to help alleviate immune responses during flare ups, potentially reducing the symptoms associated with this.”

They can be administered intravenously or via an injection at site, for example, in the intestines. It is viable that cell therapy of this kind could alleviate the symptoms associated with Crohn’s.”

Read the full and original article here.

This has also been featured in The Independent.

Explore more

Contact the team

We look forward to hearing from you.